COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 381: Articles 3801-3810  | Next

COVID-19 ORF3a Viroporin Influenced Common and Unique Cellular Signalling Cascades in Lung, Heart and Brain Choroid Plexus Organoids with Additional Enriched MicroRNA Network Analyses for Lung and Brain Tissues
Chakraborty, S., Chatterjee, S., Mardi, S., Mahata, J., Kateriya, S., Punnakkal, P., Anirudhan, G.
10.1101/2023.09.20.558551 — Posted: 2023-09-21
Adapting COVID-19 research infrastructure to capture Influenza and Respiratory Syncytial Virus alongside SARS-CoV-2 in UK healthcare workers Winter 2022/23 and beyond: protocol for a pragmatic sub-study
Broad, J., Sparkes, D., Platt, N., Howells, A., Foulkes, S., Khawam, J., cole, m., Andrews, n., Watson, C., Hopkins, S., Hall, V. J.
10.1101/2023.09.19.23295789 — Posted: 2023-09-20
Automatic Population of the Case Report Forms for an International Multifactorial Adaptive Platform Trial Amid the COVID-19 Pandemic
King, A. J., Higgins, L., Au, C., Malakouti, S., Music, E., Kalchthaler, K., Clermont, G., Garrard, W., Huang, D. T., McVerry, B. J., Seymour, C. W., Linstrum, K., McNamara, A., Green, C., Loar, I. D., Roberts, T., Marroquin, O., Angus, D. C., Horvat, C. M.
10.1101/2023.09.19.23295797 — Posted: 2023-09-20
Analysis of SARS-CoV-2 Ig seroprevalence in Northern Ireland
Greene, M. K., Smyth, P., English, A., McLaughlin, J., Bucholc, M., Bailie, J., McCarroll, J., McDonnell, M., Watt, A., Barnes, G., Lynch, M., Duffin, K., Duffy, G., Lewis, C., James, J. A., Ford, T., O'Kane, M., Rai, T. S., Bjourson, A. J., Cardwell, C., Elborn, J. S., Gibson, D. S., Scott, C. J.
10.1101/2023.09.19.23295776 — Posted: 2023-09-20
Continued selection on cryptic SARS-CoV-2 observed in Missouri wastewater
Gregory, D., Rushford, C., Lin, C.-H., Darby, C., Niehues, N., Semkiw, E., Reynolds, M., Wenzel, J., Johnson, M. C.
10.1101/2023.09.18.23295717 — Posted: 2023-09-20
ACE2-Coated Virus-Like Particles Effectively Block SARS-CoV-2 Infection
Bayraktar, C., Kayabolen, A., Odabas, A., Durgun, A., Kok, I., Sevinc, K., Supramaniam, A., Idris, A., Bagci-Onder, T.
10.1101/2023.09.19.558424 — Posted: 2023-09-20
Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2
Connor, R. I., Sakharkar, M. I., Rappazzo, C. G., Kaku, C. I., Curtis, N. C., Shin, S., Wieland-Alter, W. F., Weiner, J. A., Ackerman, M. E., Walker, L. M., Lee, J., Wright, P. F.
10.1101/2023.09.19.558444 — Posted: 2023-09-20
Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, Against SARS-CoV-2 Challenge in Nonhuman Primates
Awasthi, M., Macaluso, A., Myscofski, D., Prigge, J., Koide, F., Noyce, R. S., Fogarty, S., Stillwell, H., Goebel, S. J., Daugherty, B., Nasar, F., Bavari, S., Lederman, S.
10.1101/2023.09.19.558485 — Posted: 2023-09-20
High-affinity binding to the SARS-CoV-2 spike trimer by a nanostructured, trivalent protein-DNA synthetic antibody
Xu, Y., Zheng, R., Prasad, A., Liu, M., Wan, Z., Zhou, X., Porter, R. M., Sample, M., Poppleton, E., Procyk, J., Liu, H., Li, Y., Wang, S., Yan, H., Sulc, P., Stephanopoulos, N.
10.1101/2023.09.18.558353 — Posted: 2023-09-19
Sex-specific differences in physiological parameters related to SARS-CoV-2 infections among a national cohort (COVI-GAPP study)
Grossmann, K., Risch, M., Markovic, A., Aeschbacher, S., Weideli, O. C., Velez, L., Kovac, M., Pereira, F., Wohlwend, N., Risch, C., Hillmann, D., Lung, T., Renz, H., Twerenbold, R., Rotenbühler, M., Leibovitz, D., Kovacevic, V., Klaver, P., Brakenhoff, T. B., Franks, B., Mitratza, M., Downward, G. S., Dowling, A., Montes, S., Grobbee, D. E., Cronin, M., Conen, D., Goodale, B. M., Risch, L., COVID-RED consortium
10.1101/2023.09.17.23295693 — Posted: 2023-09-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).